ADIL
Adial Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.96
+0.09 ▲ +4.81%
🌙 3월 13일 7:54 PM ET (한국 3/14 08:54)
$1.97
+0.01 ▲ +0.75%
| Index | - | P/E | - | EPS (ttm) | -16.95 | Insider Own | 2.65% | Shs Outstand | 0.00B | Perf Week | 7.1% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | 60.2% | Insider Trans | - | Shs Float | 0.00B | Perf Month | -31.23% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | -2.58 | Inst Own | 9.91% | Short Float | 2% | Perf Quarter | -74.64% |
| Income | -0.01B | P/S | - | EPS this Y | 43.56% | Inst Trans | 1.19% | Short Ratio | 0.38 | Perf Half Y | -77.77% |
| Sales | 0.00B | P/B | 0.41 | EPS next 5Y | 47.87% | ROA | -134.29% | Short Interest | 0.03M | Perf YTD | -64.36% |
| Book/sh | 4.75 | P/C | 0.48 | EPS past 3/5Y | 88.55% 53.46% | ROE | -170.73% | 52W High | -93.52% ($30.25) | Perf Year | -88.3% |
| Cash/sh | 4.12 | P/FCF | - | Sales past 3/5Y | - | ROIC | -151.18% | 52W Low | 27.27% ($1.54) | Perf 3Y | -99.26% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 80.49% | Gross Margin | - | Volatility(W/M) | 12.16% 12.36% | Perf 5Y | -99.88% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.29 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.42 | EPS Q/Q | 77.53% | Profit Margin | - | RSI (14) | 26.4 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.42 | Sales Q/Q | - | SMA20 | -13.69% ($2.27) | Beta | 1.37 | Target Price | $23.33 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | -50.64% ($3.97) | Rel Volume | 0.44 | Prev Close | $1.87 |
| Employees | 6 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 10.56% - | SMA200 | -75.51% ($8) | Avg Volume(3M) | 0.07M | Price | $1.96 |
| IPO | 2018/7/27 | Option/Short | No/Yes | Trades | 304 | Volume | 31,604 | Change | 4.81% |
뉴스 로딩 중...